DELPHX ANNOUNCES CLOSING OF NON-BROKERED UNIT PRIVATE PLACEMENT

Rhea-AI Summary

DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non‑brokered unit private placement on March 20, 2026, issuing 4,360,000 units at C$0.05 per unit for gross proceeds of C$218,000. Each unit includes one common share and one warrant exercisable at C$0.08 for two years. Securities are subject to a four‑month plus one‑day hold and completion is subject to TSX Venture Exchange approval. Net proceeds are intended for working capital and corporate overhead.

Positive

• Raised C$218,000 gross proceeds from the offering
• Net proceeds earmarked for working capital/corporate overhead

Negative

• Issued 4,360,000 units causing immediate share issuance and potential dilution
• Warrants exercisable at C$0.08 for two years create future dilution risk if exercised
• Closing is subject to TSXV approval, which could delay completion

Toronto, March 20, 2026 (GLOBE NEWSWIRE) -- DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) (“DelphX”), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on March 18, 2026 issuing 4,360,000 units (the “Units”) at a subscription price of C$0.05 per Unit, for gross proceeds of C$218,000 (“the Offering”). Each Unit consists of one common share (“Common Share”) and one Common Share purchase warrant (“Warrant”). Each Warrant entitles the holder to purchase one Common Share at a price of $0.08, for a period of two years from the date of issuance.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with working capital/corporate overhead.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

 

For more information about DelphX, please visit www.delphx.com

George Wentworth,
General Manager DelphX Capital Markets Inc.
george.wentworth@delphx.com

(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FAQ

What did DelphX (DPXCF) announce on March 20, 2026 about the private placement?

DelphX closed a non‑brokered unit private placement issuing 4,360,000 units for C$218,000. According to the company, each unit includes one common share and one warrant exercisable at C$0.08 for two years.

How much did DelphX (DPXCF) raise and what will the proceeds be used for?

The offering raised gross proceeds of C$218,000 and net proceeds will fund working capital and corporate overhead. According to the company, proceeds are intended to support near‑term operational expenses and administration.

What are the warrant terms included in DelphX (DPXCF) unit offering?

Each warrant allows purchase of one common share at C$0.08 for two years from issuance. According to the company, warrants accompany each unit and carry a two‑year exercise window at the stated price.

Will the new securities from DelphX (DPXCF) be tradable immediately?

The securities are subject to a hold period of four months plus one day from issuance. According to the company, purchasers must hold the issued securities until the statutory hold period expires.

Is the DelphX (DPXCF) offering final or subject to regulatory approval?

Completion of the offering is subject to approval by the TSX Venture Exchange. According to the company, the issuance closed but remains conditional on TSXV final acceptance and any related requirements.